SRINIVAS AKKARAJU
@srinivasakkaraju
Director
Building Principia Biopharma Inc. as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Chinook Therapeutics U.S., Inc. was founded in 2018 and has no closure on record.
Named alongside
At Chinook Therapeutics U.S., Inc.
- Alan GlicklichExecutive Officer
- Andrew KingExecutive Officer
- Eric DobmeierExecutive Officer, Director
- Jerel DavisDirector
- Jeremy CaldwellDirector
- Paul EisenbergDirector
- Preston KlassenDirector
- Sam HallDirector
- Alan B. ColowickDirector
- Alan ColowickDirector
- David M. GoldsteinExecutive Officer
- Derrick R. RichardsonExecutive Officer
- James B. TananbaumDirector
- James TananbaumDirector
- John R. SchroerExecutive Officer
- Jorn DrappaExecutive Officer
At Mineralys Therapeutics, Inc.
- Adam LevyExecutive Officer
- Alexander AsamDirector
- Brian Taylor SlingsbyDirector
- Derek DiRoccoDirector
- Jon CongletonExecutive Officer, Director
- Olivier LitzkaDirector
- Takeshi TakahashiDirector
- Cory FreedlandDirector
- Edward FlemingDirector
- Evan RachlinDirector
- Gangadhara GanapatiExecutive Officer, Director
- Mani SubramanianExecutive Officer, Director
- Matthew YoungDirector
- Muzammil MansuriDirector
- Alan ColowickDirector
- Daniel BeckerDirector
- LEWIS J. SHUSTERDirector
- MARTIN BABLERExecutive Officer, Director
- MICHAEL DYBBSDirector
- Nassim J. UsmanDirector
- NASSIM USMANDirector
- Peter J. ThompsonDirector
At Syros Pharmaceuticals, Inc.
- Amir NashatDirector
- Andrew C. OhDirector
- Conely C. CheeExecutive Officer
Contribution
SRINIVAS's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Principia Biopharma Inc.Pharmaceutical Preparations; filing with the SEC since 2011Director · Biotechnology · SOUTH SAN FRANCISCO, United States
- Syros Pharmaceuticals, Inc.Pharmaceutical Preparations; formerly LS22, Inc.; filing with the SEC since 2012Director · Biotechnology · CAMBRIDGE, United States
- Chinook Therapeutics U.S., Inc.Director · Other Technology · Seattle, United States · Founded 2018
- Mineralys Therapeutics, Inc.Pharmaceutical Preparations; listed on Nasdaq as MLYS; filing with the SEC since 2022Director · Pharmaceuticals · RADNOR, United States · Founded 2019
- OrsoBio, Inc.Director · Biotechnology · PALO ALTO, United States · Founded 2020
- FL2021-001, Inc.Pharmaceutical Preparations; formerly FL2021-001, Inc.; listed on Nasdaq as ALMS; filing with the SEC since 2021Director · Pharmaceutical Preparations · SAN FRANCISCO, United States · Founded 2021